Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts.
about
Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiationCritical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in boneRegulation of interleukin-6 expression in osteoblasts by oxidized phospholipidsDecreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activityIdentification of the Raf-1 signaling pathway used by cAMP to inhibit p42/p44 MAPK in rat lacrimal gland acini: role in potentiation of protein secretion.p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche.CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts.Osteoporotic fracture and parathyroid hormone.Disruption of parathyroid hormone and parathyroid hormone-related peptide receptor phosphorylation prolongs ERK1/2 MAPK activation and enhances c-fos expressionCritical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal developmentA-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytesRole of PTH1R internalization in osteoblasts and bone mass using a phosphorylation-deficient knock-in mouse model.Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.MKP1-dependent PTH modulation of bone matrix mineralization in female mice is osteoblast maturation stage specific and involves P-ERK and P-p38 MAPKs.The small GTPase RhoA is crucial for MC3T3-E1 osteoblastic cell survival.PTH and PTHrP signaling in osteoblastsNeuropeptide Y1 Receptor Regulates Glucocorticoid-Induced Inhibition of Osteoblast Differentiation in Murine MC3T3-E1 Cells via ERK Signaling.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression.Parathyroid hormone-potentiated connective tissue growth factor expression in human renal proximal tubular cells through activating the MAPK and NF-kappaB signalling pathways.Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells.ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK.Brain-derived neurotrophic factor stimulates bone/cementum-related protein gene expression in cementoblasts.Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity.Epac- and Ca2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors.Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes.The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaeniaParathyroid hormone induces mitogen-activated kinase phosphatase 1 in murine osteoblasts primarily through cAMP-protein kinase A signaling.Dexamethasone-related osteogenic differentiation of dental follicle cells depends on ZBTB16 but not Runx2.Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid Hormone.
P2860
Q24314684-32F53EFB-7A9C-4692-86E0-1BEE97C50321Q27338722-C95BD4E6-D45D-4FF2-ACF9-B31B40D355E8Q33784464-1ED8D47B-4DAF-45C9-A970-6EDB38307633Q34220388-1AAC644A-4FC3-4DF0-8418-892E22B35C8FQ34299031-90726BDD-5C9C-4E9E-9946-081F191B8130Q34662181-9828BF53-B6BC-49E2-BE06-01D92E72F0F2Q34777301-8F85A99E-33F8-48D0-AB0F-9233B2462232Q35230062-32313F66-32CB-467A-BE5D-A201C20B7970Q35825410-49DFA9B0-6990-4A65-B593-BD9EFB0FEA1DQ36041890-63C00547-7935-4B13-9FED-96352C5E35DDQ36117930-5F5774C0-4EA3-44DC-9E1C-FB0414B0B2C3Q36421146-4C964BB2-0D3B-411D-96FA-8BBE1DCB9AA6Q37166245-D59C9809-D0CF-4597-8509-4FFE46723FEDQ37198198-0F123B64-E373-44E2-B56C-8EA46ED5988BQ37230119-E1046761-782F-4D4D-9A67-2692164F16A1Q37243706-92B5859B-2039-4D04-BA10-844BF46E1026Q37297529-1EA7267D-6D8A-458D-A684-930D96D29724Q37534986-925989D8-6A6F-4B93-B923-33C71DA9F671Q37615017-031F9352-E5A3-492F-BA6F-38116A163834Q38333326-0B7DF8E6-8A44-4FA1-8092-D1ED554968A7Q39660878-80AB37C6-982F-47C7-8C9F-D373C342003DQ39847587-F7BBC9C4-EA01-4934-9873-C48470CAD3EAQ39900849-6C0AD318-4B46-4DD2-AE86-022E2ADC93B0Q39994919-5D717F3B-BB5F-4E59-8D06-A69042A68790Q40154590-AA5610E9-7BED-491E-8749-F163FF441EEDQ40524023-E1AA02D2-71B5-4899-9C8A-6E4CC3243D10Q42141293-5BA32D01-D9C4-4122-8211-C61DC8C89B8AQ42693846-7C854332-6BD4-49F5-81A6-A94F6853642DQ46927975-E5080533-9D2D-4ADA-8DB7-EB1C38A69896Q50471704-FA219383-0D6F-4C2B-8CFA-06B7D2D3D36BQ52656382-E1A345B9-15CC-4608-9A93-58CCA3A111D4Q54229745-D5AFF36C-7542-409B-B789-7720702D2D70
P2860
Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Impact of the mitogen-activate ...... rotein actions in osteoblasts.
@en
type
label
Impact of the mitogen-activate ...... rotein actions in osteoblasts.
@en
prefLabel
Impact of the mitogen-activate ...... rotein actions in osteoblasts.
@en
P2093
P2860
P356
P1476
Impact of the mitogen-activate ...... rotein actions in osteoblasts.
@en
P2093
Evan T Keller
Guozhi Xiao
Jian Zhang
Laurie K McCauley
Nabanita S Datta
Nisha J D'Silva
Renny T Franceschi
P2860
P304
29121-29129
P356
10.1074/JBC.M313000200
P407
P577
2004-05-05T00:00:00Z